MedPath

the effects of oral rise with 0/2 and 2% chlorhexidine on oropharyngeal colonization and ventilator associated pneumonia

Not Applicable
Conditions
ventilator associated pneumonia.
other acute lower respiratory infections
J20-J22
Registration Number
IRCT2015100624382N1
Lead Sponsor
Vice chancellor for research of Shiraz University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
112
Inclusion Criteria

18 years and older; informed consent; patients intubated and who on mechanical ventilation within 48 hours of admission; without a clinical diagnosis of pneumonia at the time of admission ; not to be pregnant ; without significant oral, facial trauma; not to readmitted to the ICU ; without known hypersensitivity to chlorhexidine; without an immunosuppression (disease or drug induced, e.g. organ transplant patient or those on long term steroid therapy); not to hospitalized for burn injury.
Exclusion criteria: aspiration; a diagnosed thrombocytopenia (platelet less than 40000); INR above 2 or other coagulopathy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oropharyngeal colonization. Timepoint: before intervention and if had exclusion criteria. Method of measurement: send culture and report semiquantitative.
Secondary Outcome Measures
NameTimeMethod
Ventilator associated pneumonia. Timepoint: before, during and until 48hours and if had exclusion criteria. Method of measurement: clinical pulmonary infection score and clinical diagnose and start new antibiotic by intensivist.
© Copyright 2025. All Rights Reserved by MedPath